Innovative research focused on progress toward a cure
Hamm Diabetes Center's research group is one of the top-funded and largest in the world. The advances in our laboratories are being translated into dramatically improved patient care for those suffering from diabetes and its complications.
See "In This Section" menu to navigate to Research content areas.
2020 Funded Grants
Team Science Grants
William Hildebrand, PhD: Type 1 Diabetes Immune Targets ($50,000)
David Sparling, M.D., PhD: Infant Gut Microbial Species and Programming Innate Immunity ($99,969)
Karen Jonscher, PhD: Role of CRISPLD2 in Adipose Function ($100,000)
Dean Myers, PhD: Development of a Baboon Model of Western Diet and Maternal Obesity-Mechanisms for Fetal Epigenetic Programming of Behavior and Metabolism ($100,000)
Stephanie Pierce, M.D.: Pilot RCT Intervention Targeting Elevated Triglycerides with a Point-of-Care Meter and Omega-3 Fatty Acids to Normalize Triglycerides and Fetal Growth ($99,322)
Equipment Grants
Martin-Paul Agbaga, PhD: Headspace Sampler for Short Chain Fatty Acids Analyses ($34,778)
Michael Rudolph, PhD: A Comprehensive and Dedicated Rodent Metabolic Phenotyping Resource ($500,000)
Susan Sission, PhD: Request to Purchase: Veggie Meter ($27,555)
Sowmya Krishnan, M.D.: Bone Microarchitecture in Adolescents and Young Adults with Diabetes ($10,208.59)
Carol Dionne, PT, DPT, PhD, MS, OCS, Cert MDT: Expanding Investigation Capabilities at the Center for Human Performance Measurement ($54,553.11)
Research at the Root (2018)
This report elucidates the ways HHDC answers the call for progress against the pandemic of diabetes and its complications.
CLICK HERE to view the virtual book (external website)
CLICK HERE to download the report (PDF)
Research is not limited to the laboratory. Learn about Clinical Trials at the Hamm Diabetes Center.